Group 1 - The core viewpoint of the article is that Tianchen Medical has signed a strategic cooperation agreement with Inspur Digital Technology (Shanghai) Co., Ltd. to promote innovation and industrialization in medical intelligent manufacturing and robotic development [1] - The agreement is part of the company's dual-engine strategy, which focuses on minimally invasive capabilities driven by end-execution components and the intelligent ecosystem of surgical robots supported by the MA platform [1] - The signing of the strategic cooperation agreement is significant for establishing a long-term partnership and provides a framework for future project collaborations, facilitating industrial integration and mutual benefits for both parties [1]

Core Viewpoint - Tianchen Medical (688013) has signed a strategic cooperation agreement with Inspur Digital Technology (Shanghai) Co., Ltd. to enhance innovation and industrialization in medical intelligent manufacturing and robotics by leveraging both parties' resources [1] Group 1: Strategic Cooperation - The agreement aims to promote the intelligentization and information technology in medical devices and consumables, as well as the research and production of medical robots [1] - This partnership is a significant step in implementing Tianchen Medical's dual-engine strategy, which focuses on minimally invasive capabilities driven by end-execution components and an intelligent ecosystem for surgical robots supported by the MA platform [1] - The signing of the agreement establishes a strategic partnership, providing a framework for future project collaborations and facilitating industrial integration and mutual benefits [1]

Core Viewpoint - Tianchen Medical (688013.SH) has signed a strategic cooperation agreement with Inspur Digital Technology (Shanghai) Co., Ltd. to promote innovation and industrialization in medical intelligent manufacturing and robotics by December 31, 2025 [1] Group 1: Strategic Cooperation - The agreement aims to advance the intelligent manufacturing of medical devices and consumables, as well as the research and production of medical robots [1] - This strategic partnership is a significant step in implementing the company's dual-engine strategy, which focuses on minimally invasive capabilities driven by end-execution components and an intelligent ecosystem for surgical robots supported by the MA platform [1] - The signing of the agreement establishes a long-term cooperative relationship and provides a framework for future project collaborations, facilitating industrial integration and mutual benefits for both parties [1]

Core Viewpoint - Tianchen Medical (688013.SH) has signed a strategic cooperation agreement with Inspur Digital Technology (Shanghai) Co., Ltd. to promote innovation and industrialization in medical intelligence and information technology [1] Group 1 - The agreement was signed on December 31, 2025, indicating a long-term partnership between the two companies [1] - The collaboration aims to focus on intelligent manufacturing of medical devices and consumables, as well as the research and production of medical robots [1]

Group 1 - The core viewpoint of the article is that Tianchen Medical (688013.SH) has signed a strategic cooperation agreement with Inspur Digital Technology (Shanghai) Co., Ltd. to promote innovation and industrialization in medical intelligence and information technology [1] Group 2 - The agreement was signed on December 31, 2025, indicating a future-oriented collaboration between the two companies [1] - The focus areas of the collaboration include intelligent manufacturing of medical devices and consumables, as well as the research and production of medical robots [1]

Group 1 - Tianchen Medical announced a strategic cooperation agreement with Inspur Digital Technology (Shanghai) Co., Ltd. to leverage both parties' resource advantages in promoting the intelligentization and information technology in medical devices and consumables manufacturing, as well as the research and production of medical robots [1] - The strategic cooperation agreement is set to be signed by December 31, 2025, focusing on innovative applications and industrialization in the healthcare sector [1] Group 2 - The news highlights the growing trend of collaboration between technology companies and healthcare providers to enhance medical technology and services [1]

格隆汇1月5日丨天臣医疗(688013.SH)公布，天臣医疗与浪潮数字科技（上海）有限公司（简称"浪潮数 科"）本着充分发挥双方资源优势，共同推动医疗智能化、信息化技术在医疗器械设备与耗材的智能化 制造、医疗机器人研发生产等领域的创新应用与产业化落地的战略协同原则，共同商定并于2025年12月 31日签署了《战略合作协议》。 ...

证券代码：688013 证券简称：天臣医疗 公告编号：2026-001 天臣国际医疗科技股份有限公司 关于自愿披露签订战略合作协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 履约的重大风险及不确定性：本次签订的战略合作协议不涉及金额，具 体合作内容以双方另行签订的合同为准。本协议为双方基于未来合作意向签署的 框架性、原则性协议，不构成对具体合作项目、实施进度或商业成果的实质性承 诺。协议履行过程中，若受行业政策调整、市场环境变化等不可预见因素或不可 抗力影响，可能导致协议无法如期履行或履行效果未达预期。公司将根据协议履 行情况及后续合作进展，按照《上海证券交易所科创板股票上市规则》等相关法 律法规、规范性文件的规定，及时履行信息披露义务，敬请投资者注意投资风险。 对公司业绩的影响：本协议属于框架性协议，预计对天臣国际医疗科技 股份有限公司（以下简称"公司"或"天臣医疗"）2026 年度及未来业绩不构 成直接影响，对公司业绩的具体影响需视下一步具体项目推进和实施情况来确定。 一、战略合作协议签订的 ...

Core Viewpoint - The company has signed a strategic cooperation agreement with Inspur Digital Technology (Shanghai) Co., Ltd. to promote innovation and industrialization in medical intelligence and information technology [1] Group 1: Cooperation Details - The cooperation aims to advance intelligent manufacturing of medical devices and consumables, as well as the research and production of medical robots [1] - Key areas of collaboration include medical intelligence and information, smart medical devices, medical robots, market synergy, and brand co-construction [1] Group 2: Agreement Impact - The agreement is effective upon the affixing of official seals by both parties and is expected to guide long-term cooperation [1] - It is anticipated that the agreement will not have a direct impact on the company's performance for the fiscal year 2026 and beyond [1]

Core Insights - The Chinese open stapler market is experiencing a decline, with the market size decreasing from 15.3 billion yuan in 2020 due to the pandemic, and projected to reach 14.1 billion yuan in 2024, a year-on-year decrease of 2.1% [2] - The decline is attributed to the shift towards minimally invasive surgical techniques, with laparoscopic staplers becoming the mainstream due to their advantages such as less trauma and faster recovery [2] - Despite the decline, open staplers still hold irreplaceable value in grassroots medical settings and complex surgeries, indicating a potential stabilization in market size, although their market share is expected to continue decreasing [2] Industry Overview - Open staplers are primarily used in traditional open surgeries, offering advantages such as quick suturing, ease of use, single-use to prevent cross-infection, and fewer complications [3][4] - The types of open staplers include linear staplers, tubular digestive tract staplers, linear cutting staplers, anal staplers, purse-string staplers, curved cutting staplers, and skin staplers, each with specific applications [4] - The industry chain consists of upstream material suppliers, midstream manufacturers, and downstream consumers such as hospitals and clinics [6] Market Dynamics - The number of medical institutions in China is on the rise, projected to reach 1,093,600 by 2024, which will increase the demand for open staplers [8] - The competition in the open stapler market is shifting towards product upgrades and cost control as the market space contracts [10]